Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease (SIOVAC)

This study has been completed.
Sponsor:
Collaborators:
Instituto de Salud Carlos III
Fundación de Investigación en Red en Enfermedades Cardiovasculares
Information provided by (Responsible Party):
Hospital General Universitario Gregorio Marañon
ClinicalTrials.gov Identifier:
NCT00862043
First received: March 13, 2009
Last updated: September 22, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2016
  Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)